News > Remdesivir improves time to recovery in COVID-19 patients

Remdesivir improves time to recovery in COVID-19 patients

One India | 27/05/2020 02:21 PM | Click to read full article

The preliminary findings, based on an analysis of 1059 participants, noted that patients who received remdesivir had a shorter time to recovery than those who received placebo. The median time for this, the researchers said, was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo. The study also suggested a survival benefit, with a 14-day mortality rate of 7 per cent for the group receiving remdesivir compared to nearly 12 per cent for the placebo group.